Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 96

1.

Predictors of Visual Acuity Outcomes Following Vitrectomy for Idiopathic Macular Hole.

Amram AL, Mandviwala MM, Ou WC, Wykoff CC, Shah AR.

Ophthalmic Surg Lasers Imaging Retina. 2018 Aug 1;49(8):566-570. doi: 10.3928/23258160-20180803-03.

PMID:
30114300
2.

When and How to Incorporate Steroids for Persistent Diabetic Macular Edema: A Discussion of Real-World Treatment Optimization Strategies.

Eichenbaum DA, Buznego C, Weng CY, Dhoot DS, Wykoff CC, Sheth VS.

Ophthalmic Surg Lasers Imaging Retina. 2018 Jul 1;49(7):S5-S15. doi: 10.3928/23258160-20180621-01.

PMID:
30021031
3.

Ultra-Wide-Field Fluorescein Angiography-Guided Normalization of Ischemic Index Calculation in Eyes With Retinal Vein Occlusion.

Wang K, Ghasemi Falavarjani K, Nittala MG, Sagong M, Wykoff CC, van Hemert J, Ip M, Sadda SR.

Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3278-3285. doi: 10.1167/iovs.18-23796.

PMID:
29971447
4.

Five-Year Outcomes of Surgically Treated Symptomatic Epiretinal Membranes With and Without Internal Limiting Membrane Peeling.

Sultan H, Wykoff CC, Shah AR.

Ophthalmic Surg Lasers Imaging Retina. 2018 May 1;49(5):296-302. doi: 10.3928/23258160-20180501-02.

PMID:
29772039
5.

Topographic Correspondence of Macular Atrophy With Choroidal Neovascularization in Ranibizumab-treated Eyes of the TREX-AMD Trial.

Abdelfattah NS, Hariri AH, Al-Sheikh M, Pitetta S, Ebraheem A, Wykoff CC, Sadda SR; TREX-AMD Study Group.

Am J Ophthalmol. 2018 Aug;192:84-90. doi: 10.1016/j.ajo.2018.05.008. Epub 2018 May 12.

PMID:
29763612
6.

Retinopathy Regression with Treat and Extend Ranibizumab for Diabetic Macular Edema.

Payne JF, Clark WL, Bruce BB, Wykoff CC, Brown DM, Menke BM, Iverson SM, Allen KF, Boyer DS; Treat & Extend Protocol in Patients with Diabetic Macular Edema Study Group.

Ophthalmology. 2018 Aug;125(8):1304-1306. doi: 10.1016/j.ophtha.2018.03.046. Epub 2018 May 3. No abstract available.

PMID:
29729809
7.

Changes in retinal ischaemic index correlate with recalcitrant macular oedema in retinal vein occlusion: WAVE study.

Kwon S, Wykoff CC, Brown DM, van Hemert J, Fan W, Sadda SR.

Br J Ophthalmol. 2018 Aug;102(8):1066-1071. doi: 10.1136/bjophthalmol-2017-311475. Epub 2018 Apr 26.

PMID:
29699979
8.

Longitudinal Quantification of Retinal Nonperfusion in the Macula of Eyes With Retinal Vein Occlusion Receiving Anti-VEGF Therapy: Secondary Analysis of the WAVE Randomized Trial.

Ou WC, Lampen SIR, Wykoff CC.

Ophthalmic Surg Lasers Imaging Retina. 2018 Apr 1;49(4):258-264. doi: 10.3928/23258160-20180329-08.

PMID:
29664983
9.

Identification of factors to increase efficacy of telemedicine screening for diabetic retinopathy in endocrinology practices using the Intelligent Retinal Imaging System (IRIS) platform.

Naik S, Wykoff CC, Ou WC, Stevenson J, Gupta S, Shah AR.

Diabetes Res Clin Pract. 2018 Jun;140:265-270. doi: 10.1016/j.diabres.2018.04.011. Epub 2018 Apr 9.

PMID:
29649538
10.

Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.

Jampol LM, Glassman AR, Liu D, Aiello LP, Bressler NM, Duh EJ, Quaggin S, Wells JA, Wykoff CC; Diabetic Retinopathy Clinical Research Network.

Ophthalmology. 2018 Jul;125(7):1054-1063. doi: 10.1016/j.ophtha.2018.01.019. Epub 2018 Mar 7.

PMID:
29525602
11.

Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration.

Wykoff CC, Clark WL, Nielsen JS, Brill JV, Greene LS, Heggen CL.

J Manag Care Spec Pharm. 2018 Feb;24(2-a Suppl):S3-S15. doi: 10.18553/jmcp.2018.24.2-a.s3.

12.

Subfoveal choroidal thickness predicts macular atrophy in age-related macular degeneration: results from the TREX-AMD trial.

Fan W, Abdelfattah NS, Uji A, Lei J, Ip M, Sadda SR, Wykoff CC; TREX-AMD Study Group.

Graefes Arch Clin Exp Ophthalmol. 2018 Mar;256(3):511-518. doi: 10.1007/s00417-017-3888-2. Epub 2018 Jan 27.

PMID:
29374796
13.

Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion: Three-Year Randomized DAVE Trial.

Brown DM, Ou WC, Wong TP, Kim RY, Croft DE, Wykoff CC; DAVE Study Group.

Ophthalmology. 2018 May;125(5):683-690. doi: 10.1016/j.ophtha.2017.11.026. Epub 2018 Jan 11.

14.

Positive Visual Phenomena Following Implantation of the Argus II Retinal Prosthesis.

Sadaka A, Iqbal C, Nazari H, Berry S, Wykoff CC, Humayun MS, Lee AG.

Ophthalmic Surg Lasers Imaging Retina. 2017 Dec 1;48(12):1022-1025. doi: 10.3928/23258160-20171130-11.

PMID:
29253307
15.

Intravitreal aflibercept for proliferative diabetic retinopathy.

Brown DM, Wykoff CC.

Lancet. 2017 Nov 11;390(10108):2141. doi: 10.1016/S0140-6736(17)32445-5. Epub 2017 Nov 9. No abstract available.

PMID:
29143753
16.

Long-term outcomes with as-needed aflibercept in diabetic macular oedema: 2-year outcomes of the ENDURANCE extension study.

Wykoff CC, Ou WC, Khurana RN, Brown DM, Lloyd Clark W, Boyer DS; ENDURANCE Study Group.

Br J Ophthalmol. 2018 May;102(5):631-636. doi: 10.1136/bjophthalmol-2017-310941. Epub 2017 Aug 16.

PMID:
28814412
17.

Neovascular age-related macular degeneration management in the third year: final results from the TREX-AMD randomised trial.

Wykoff CC, Ou WC, Croft DE, Payne JF, Brown DM, Clark WL, Abdelfattah NS, Sadda SR; TREX-AMD Study Group.

Br J Ophthalmol. 2018 Apr;102(4):460-464. doi: 10.1136/bjophthalmol-2017-310822. Epub 2017 Aug 4.

PMID:
28779006
18.

Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412-418.

Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, Wykoff CC, Gardner TW.

Diabetes Care. 2017 Sep;40(9):1285. doi: 10.2337/dc17-er09. Epub 2017 Jul 13. No abstract available.

19.

Distribution of Nonperfusion Area on Ultra-widefield Fluorescein Angiography in Eyes With Diabetic Macular Edema: DAVE Study.

Fan W, Wang K, Ghasemi Falavarjani K, Sagong M, Uji A, Ip M, Wykoff CC, Brown DM, van Hemert J, Sadda SR.

Am J Ophthalmol. 2017 Aug;180:110-116. doi: 10.1016/j.ajo.2017.05.024. Epub 2017 Jun 1.

PMID:
28579062
20.

Relationship Between Visual Acuity and Retinal Thickness During Anti-Vascular Endothelial Growth Factor Therapy for Retinal Diseases.

Ou WC, Brown DM, Payne JF, Wykoff CC.

Am J Ophthalmol. 2017 Aug;180:8-17. doi: 10.1016/j.ajo.2017.05.014. Epub 2017 May 24.

PMID:
28549848

Supplemental Content

Loading ...
Support Center